Suspected Interference in E-Cigarette Regulation by Special Interest Groups

Sep.20.2024
Suspected Interference in E-Cigarette Regulation by Special Interest Groups
Indonesian MP Mukhamad Misbakhun suspects certain interest groups influencing e-cigarette regulations for potential company benefits.

According to the Indonesian media Liputan6 on September 19, 2024, Mukhamad Misbakhun, a member of the eleventh committee of the House of Representatives of the Republic of Indonesia, suspects that certain interest groups are interfering with the regulations in the draft Ministerial Regulation on the Safety of Tobacco and E-cigarette Products (RPMK), which could benefit certain e-cigarette companies.


Mr. Misbah pointed out that there is inconsistency between Article 3 and Article 7 of the draft. Article 3, paragraph 1 of the Tobacco Control Regulations stipulates that the scope of application of the Minister of Health's regulations includes standardizing the packaging of tobacco products and e-cigarette products. Paragraph 3 of Article 3 further specifies that e-cigarette products include the following: open or refillable nicotine e-liquid systems; closed or disposable pod systems; and solid forms.


However, the first provision of Article 7 regarding standardized packaging only covers open system or refillable e-cigarette products. The second provision of Article 7 regulates the packaging of closed systems (i.e. pods). Misbah emphasized that solid e-cigarettes have not been further regulated, and he suspects that there may be influence from global tobacco companies requesting the Ministry of Health not to regulate and control solid e-cigarettes, as these products are mainly imported solid products.


Previously, the government regulation issued by the Ministry of Health on 28/2024 had sparked opposition from various parties, including stakeholders in the tobacco industry. Currently, the Ministry of Health is finalizing the RPMK draft, however, this draft is also facing criticism and opposition from various sides.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
FDA Wins Default Entry in Case Against E-Cigarette Distributor, to Seek Permanent Injunction
FDA Wins Default Entry in Case Against E-Cigarette Distributor, to Seek Permanent Injunction
The U.S. Food and Drug Administration (FDA) has made procedural progress in its lawsuit against North Carolina-based e-cigarette distributor Dream Distro LLC and its owner. A federal district judge granted the government’s request for entry of default after the defendants failed to respond to the complaint within 21 days of service. The government will next seek a default judgment, including a permanent injunction.
Apr.09 by 2FIRSTS.ai
Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarette and e-liquid in new draft law, citing dangerous substances found.
Apr.08 by 2FIRSTS.ai
Imperial Brands to Close Langenhagen Cigarette Factory by 2027
Imperial Brands to Close Langenhagen Cigarette Factory by 2027
Imperial Brands said it will gradually close the Reemtsma factory in Langenhagen near Hanover by 2027 after efforts to find a buyer failed to produce a sustainable agreement. The factory has produced cigarettes since 1971 and currently affects around 600 employees. The company said it had examined all realistic options over recent months but did not receive a binding offer from a potential buyer.
Mar.27 by 2FIRSTS.ai
American Snuff Expands Manufacturing Hiring as Reynolds American Builds Future-Ready Operations
American Snuff Expands Manufacturing Hiring as Reynolds American Builds Future-Ready Operations
Reynolds American said American Snuff Company will add more than 50 manufacturing roles at its Clarksville, Tennessee facility as part of its wider U.S. manufacturing investment plan. The company said the hiring is one of the latest developments under its plan to invest more than USD 3.2 billion across U.S. operations by 2030.
Mar.27 by 2FIRSTS.ai
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai